Skip to main content
Top
Published in: Journal of Clinical Immunology 4/2009

01-07-2009

Effect of Arsenic on Regulatory T Cells

Authors: B. Hernández-Castro, L. M. Doníz-Padilla, M. Salgado-Bustamante, D. Rocha, M. D. Ortiz-Pérez, M. E. Jiménez-Capdeville, D. P. Portales-Pérez, A. Quintanar-Stephano, R. González-Amaro

Published in: Journal of Clinical Immunology | Issue 4/2009

Login to get access

Abstract

Introduction

Arsenic (As) affects the function and survival of lymphocytes, and some arsenic compounds exert a relevant antineoplastic effect. We have explored the effect of As on T regulatory cells.

Results and Discussion

In vitro experiments with peripheral blood mononuclear cells from healthy subjects showed that low concentrations of As tended to increase the number of natural T regulatory (nTreg) lymphocytes, whereas concentrations >5.0 μM had an opposite effect. Furthermore, rats exposed to As showed redistribution of nTreg cells, and As administration to rats with experimental allergic encephalomyelitis increased the levels of nTreg cells in spleen and diminished the severity of this condition. On the other hand, in 47 apparently healthy subjects chronically exposed to As, we found significant inverse correlation between urinary As levels and the number and function of nTreg lymphocytes. Although most of these individuals showed enhanced levels of apoptotic lymphocytes in peripheral blood, with a diminution of mitochondrial membrane potential, no significant correlation between these parameters and urinary As was detected.

Conclusion

Our data indicate that As seems to have a relevant and complex effect on nTreg cells.
Literature
9.
go back to reference ATSDR. Toxicological profile for arsenic: agency for toxic substances and disease register. US, Atlanta GA: Department of Health & Human Services; 1999. ATSDR. Toxicological profile for arsenic: agency for toxic substances and disease register. US, Atlanta GA: Department of Health & Human Services; 1999.
10.
go back to reference Vega L, Ostrosky-Wegman P, Fortoul TI, Diaz C, Madrid V, Saavedra R. Sodium arsenite reduces proliferation of human activated T-cells by inhibition of the secretion of interleukin-2. Immunopharmacol Immunotoxicol. 1999;21:203–20. doi:10.3109/08923979909052758.PubMedCrossRef Vega L, Ostrosky-Wegman P, Fortoul TI, Diaz C, Madrid V, Saavedra R. Sodium arsenite reduces proliferation of human activated T-cells by inhibition of the secretion of interleukin-2. Immunopharmacol Immunotoxicol. 1999;21:203–20. doi:10.​3109/​0892397990905275​8.PubMedCrossRef
11.
go back to reference Soto-Peña GA, Luna AL, Acosta-Saavedra L, et al. Assessment of lymphocyte subpopulations and cytokine secretion in children exposed to arsenic. FASEB J. 2006;20:779–81.PubMed Soto-Peña GA, Luna AL, Acosta-Saavedra L, et al. Assessment of lymphocyte subpopulations and cytokine secretion in children exposed to arsenic. FASEB J. 2006;20:779–81.PubMed
12.
go back to reference Conde P, Acosta-Saavedra LC, Gotilla-Acevedo RC, Calderón-Aranda ES. Sodium arsenite-induced inhibition of cell proliferation is related to inhibition of IL-2 mRNA expression in mouse activated T cells. Arch Toxicol. 2007;81:251–9. doi:10.1007/s00204-006-0152-7.PubMedCrossRef Conde P, Acosta-Saavedra LC, Gotilla-Acevedo RC, Calderón-Aranda ES. Sodium arsenite-induced inhibition of cell proliferation is related to inhibition of IL-2 mRNA expression in mouse activated T cells. Arch Toxicol. 2007;81:251–9. doi:10.​1007/​s00204-006-0152-7.PubMedCrossRef
13.
27.
go back to reference Urzainqui A, Martínez del Hoyo G, Lamana A, et al. Functional role of P-selectin glycoprotein ligand 1/P-selectin interaction in the generation of tolerogenic dendritic cells. J Immunol. 2007;179:7457–65.PubMed Urzainqui A, Martínez del Hoyo G, Lamana A, et al. Functional role of P-selectin glycoprotein ligand 1/P-selectin interaction in the generation of tolerogenic dendritic cells. J Immunol. 2007;179:7457–65.PubMed
28.
go back to reference Vigna-Perez M, Hernández-Castro B, Paredes-Saharopulos O, et al. Clinical and immunological effects of rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study. Arthritis Res Ther. 2006;8:R83. doi:10.1186/ar1954.PubMedCrossRef Vigna-Perez M, Hernández-Castro B, Paredes-Saharopulos O, et al. Clinical and immunological effects of rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study. Arthritis Res Ther. 2006;8:R83. doi:10.​1186/​ar1954.PubMedCrossRef
30.
31.
32.
go back to reference Chen YZ, Wu Y, Huang MJ, Lu LH. Effect of endogenous TGF-beta1 and TNF-alpha on the As(2)O(3) inducing apoptosis of HL-60 cells. Zhonghua Xue Ye Xue Za Zhi. 2003;24:231–4.PubMed Chen YZ, Wu Y, Huang MJ, Lu LH. Effect of endogenous TGF-beta1 and TNF-alpha on the As(2)O(3) inducing apoptosis of HL-60 cells. Zhonghua Xue Ye Xue Za Zhi. 2003;24:231–4.PubMed
Metadata
Title
Effect of Arsenic on Regulatory T Cells
Authors
B. Hernández-Castro
L. M. Doníz-Padilla
M. Salgado-Bustamante
D. Rocha
M. D. Ortiz-Pérez
M. E. Jiménez-Capdeville
D. P. Portales-Pérez
A. Quintanar-Stephano
R. González-Amaro
Publication date
01-07-2009
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 4/2009
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-009-9280-1

Other articles of this Issue 4/2009

Journal of Clinical Immunology 4/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.